Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Repurposing FDA‐Approved Drugs to Target MTH1 for Anticancer Therapeutics
Repurposing FDA‐Approved Drugs to Target MTH1 for Anticancer Therapeutics
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Aaliya Taiyab
,
Md Nayab Sulaimani
,
Aanchal Rathi
,
Fazlurrahman Khan
,
Afzal Hussain
,
Mohamed F. Alajmi
,
Md. Imtaiyaz Hassan
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Journal of Molecular Recognition
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://onlinelibrary.wiley.com/doi/10.1002/jmr.70005
Similar Items
Structural and Functional Insights Into Lyn Kinase: From Immune Regulation to Therapeutic Targeting
by: Alisha Khan, et al.
Published: (2026)
Integrated Virtual Screening and Molecular Dynamics Simulation Study to Discover Potential Activators of γ‐Aminobutyric Acid B Receptor 1 for Therapeutic Targeting of Neurodegenerative Diseases
by: Asfiya, et al.
Published: (2026)
ASK1 Signaling in Cancer: Pathogenic Driver or Therapeutic Target?
by: Yumna Khan, et al.
Published: (2025)
AI-Driven Drug Repurposing through miRNA-mRNA Relation
by: Manoharan, Sharanya, et al.
Published: (2025)
Cucurbitacin‐E‐Glucoside Augments Tamoxifen's Anticancer Efficacy by Targeting PPARγ and NF‐kB: In Vivo and In Silico Studies
by: Yasmin Sabry, et al.
Published: (2025)